11 – 20 of 181
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Risk of invasive penile cancer after treatment of penile intraepithelial neoplasia
- Contribution to journal › Article
-
Mark
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer : A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline Panels
- Contribution to journal › Article
-
Mark
Risk of upper urinary tract urothelial carcinoma after primary non-muscle-invasive urinary bladder cancer : A nationwide population-based cohort study
- Contribution to journal › Article
-
Mark
Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting
- Contribution to journal › Article
-
Mark
Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI) : a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study
- Contribution to journal › Article
-
Mark
Semi-standardized evaluation of extraprostatic extension and seminal vesicle invasion with [18F]PSMA-1007 PET/CT : a comparison to MRI using histopathology as reference
- Contribution to journal › Article
-
Mark
Reply to Laila Schneidewind, Fabian P. Stangl, Jennifer Kranz, and Gernot Bonkat's Letter to Editor re : Fredrik Liedberg, Evanguelos Xylinas, Paolo Gontero. Quinolone Prophylaxis in Conjunction with Bacillus Calmette-Guérin Instillations for Bladder Cancer: Time To Reconsider the Evidence and Open the Quinolone Box? Eur Urol Focus 2024;10:564–6
- Contribution to journal › Debate/Note/Editorial
-
Mark
Pre-treatment metastatic biopsy : a step towards precision oncology for urothelial cancer
- Contribution to journal › Scientific review
-
Mark
Survival patterns after perioperative treatment escalation and cystectomy for synchronous oligometastatic bladder cancer (M1a/M1b) – a population-based series
- Contribution to journal › Article
-
Mark
Kloka kliniska val och hälsoekonomiska utvärderingar
(2025) In Läkartidningen
- Contribution to journal › Debate/Note/Editorial
